Magenta Therapeutics, Inc. (13)

Browse by Contract Category

Contracts

First Amendment to Employment Agreement, executed as of October 14, 2020, by and between the Registrant and John C. Davis, Jr., M.D (Filed With SEC on November 5, 2020)
Underwriting Agreement, dated as of June 24, 2020, by and among Magenta Therapeutics, Inc. and Goldman Sachs & Co. LLC and Cowen and Company, LLC, as representatives of the... (Filed With SEC on June 30, 2020)
Description of Securities of the Registrant (Filed With SEC on March 3, 2020)
Amendment, effective as of July 4, 2019, pursuant to the Exclusive Research, Development Option and License Agreement by and between the Registrant and Heidelberg Pharma Research... (Filed With SEC on November 13, 2019)
Amendment #1 to Project Rider #3, effective as of August 26, 2019, pursuant to the Collaboration Agreement by and between the Registrant and National Marrow Donor Program d/b/a Be... (Filed With SEC on November 13, 2019)
First Amendment to Sublease by and between Novartis Institutes for BioMedical Research, Inc. and the Registrant, dated as of December 13, 2018 (Filed With SEC on April 29, 2019)
Underwriting Agreement, dated as of June 24, 2020, by and among Magenta Therapeutics, Inc. and Goldman Sachs & Co. LLC and Cowen and Company, LLC, as representatives of the... (Filed With SEC on June 30, 2020)
2019 Employee Stock Purchase Plan (Filed With SEC on June 11, 2019)
Form of Underwriting Agreement (Filed With SEC on April 29, 2019)
Letter Agreement, effective as of February 28, 2019, by and between the Registrant and Heidelberg Pharma Research GmbH relating to the Exclusive Research, Development Option and... (Filed With SEC on April 29, 2019)
Project Rider #2, effective as of June 26, 2018, pursuant to the Collaboration Agreement by and between the Registrant and Be The Match BioTherapies, dated as of November 10, 2017 (Filed With SEC on March 19, 2019)
Project Rider #3, effective as of September 6, 2018, pursuant to the Collaboration Agreement by and between the Registrant and Be The Match BioTherapies, dated as of November 10,... (Filed With SEC on March 19, 2019)
Amendment #1 to Project Rider #1, effective as of December 6, 2018, pursuant to the Collaboration Agreement by and between the Registrant and Be The Match BioTherapies, dated as... (Filed With SEC on March 19, 2019)